Siddhartha Mahanty

Infectious Disease
4 Center Dr Rm 126NIH
Bethesda, MD 20892

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggest imprinting to the ancestral strain of SARS-CoV-2.

Antibody responses following COVID-19 vaccination and breakthrough infections in naïve and convalescent individuals suggest imprinting to the ancestral strain of SARS-CoV-2.

Journal: mBio
Published: December 10, 2025

Spatial distribution of and socio-ecological risk factors for strongyloidiasis in Australia.

Spatial distribution of and socio-ecological risk factors for strongyloidiasis in Australia.

Journal: The Journal of infection
Published: September 25, 2025

Cestode larvae excite host neuronal circuits via glutamatergic signalling.

Cestode larvae excite host neuronal circuits via glutamatergic signalling.

Journal: eLife
Published: July 04, 2025

Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination.

Dysregulated inflammation in solid tumor malignancy patients shapes polyfunctional antibody responses to COVID-19 vaccination.

Journal: NPJ vaccines
Published: June 02, 2025

Genetic markers of enhanced functional antibody responses to COVID-19 vaccination.

Genetic markers of enhanced functional antibody responses to COVID-19 vaccination.

Journal: Vaccine
Published: December 23, 2024

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

The immunogenicity, reactogenicity, and safety of a bivalent mRNA or protein COVID-19 vaccine given as a fourth dose.

Journal: The Journal of infection
Published: November 07, 2024

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.

Journal: Frontiers in immunology
Published: August 27, 2024

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.

Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.

Journal: medRxiv : the preprint server for health sciences
Published: July 23, 2024

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.

Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine.

Journal: ACS nano
Published: June 27, 2022

A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.

A recombinant monoclonal-based Taenia antigen assay that reflects disease activity in extra-parenchymal neurocysticercosis.

Journal: PLoS neglected tropical diseases
Published: January 11, 2022

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.

Prevalence of Neutralising Antibodies to HCoV-NL63 in Healthy Adults in Australia.

Journal: Viruses
Published: July 20, 2021

Tuberculosis mortality: quantifying agreement in clinical cause of death assessments.

Tuberculosis mortality: quantifying agreement in clinical cause of death assessments.

Journal: Australian and New Zealand journal of public health
Published: June 01, 2021
Showing 1-12 of 51

Last Updated: 09/26/2026